Radiomics: A radiological evidence-based artificial intelligence technique to facilitate personalized precision medicine in hepatocellular carcinoma
J Wei, H Jiang, Y Zhou, J Tian, FS Furtado… - Digestive and Liver …, 2023 - Elsevier
The high postoperative recurrence rates in hepatocellular carcinoma (HCC) remain a major
hurdle in its management. Appropriate staging and treatment selection may alleviate the …
hurdle in its management. Appropriate staging and treatment selection may alleviate the …
Precision imaging guidance in the era of precision oncology: An update of imaging tools for interventional procedures
C Floridi, M Cellina, G Irmici, A Bruno… - Journal of Clinical …, 2022 - mdpi.com
Interventional oncology (IO) procedures have become extremely popular in interventional
radiology (IR) and play an essential role in the diagnosis, treatment, and supportive care of …
radiology (IR) and play an essential role in the diagnosis, treatment, and supportive care of …
CT-based radiomics nomogram for prediction of survival after transarterial chemoembolization with drug-eluting beads in patients with hepatocellular carcinoma and …
S Cheng, G Hu, Z Jin, Z Wang, H Xue - European Radiology, 2023 - Springer
Objectives To develop and validate a CT-based radiomics model for the prediction of the
overall survival (OS) of patients with hepatocellular carcinoma (HCC) and portal vein tumor …
overall survival (OS) of patients with hepatocellular carcinoma (HCC) and portal vein tumor …
[HTML][HTML] Radiomics/Radiogenomics in hepatocellular carcinoma: Applications and challenges in interventional management
J Fu, S Cao, L Song, X Tong, J Wang, M Yang, Y Zou - Iliver, 2022 - Elsevier
Hepatocellular carcinoma is one of the leading causes of cancer-related death worldwide.
Recently, radiomics and radiogenomics have been introduced as novel dimensions in …
Recently, radiomics and radiogenomics have been introduced as novel dimensions in …
Radiomics as a tool for prognostic prediction in transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis
K Deng, T Chen, Z Leng, F Yang, T Lu, J Cao… - La radiologia …, 2024 - Springer
Introduction Transarterial chemoembolization (TACE) is one of the predominant
locoregional therapeutic modalities for addressing hepatocellular carcinoma (HCC) …
locoregional therapeutic modalities for addressing hepatocellular carcinoma (HCC) …
Radiomics analysis based on contrast-enhanced MRI for predicting short-term efficacy of drug-eluting beads transarterial chemoembolization in hepatocellular …
Z Xi, Y Ye, Y Yang, Y He, Z Song, Q Ma, H Zeng… - Abdominal …, 2024 - Springer
Objective We developed and validated a clinical-radiomics model for preoperative
prediction of the short-term efficacy of initial drug-eluting beads transarterial …
prediction of the short-term efficacy of initial drug-eluting beads transarterial …
Response Assessment of Primary Liver Tumors to Novel Therapies: an Imaging Perspective
The latest developments in cancer immunotherapy, namely the introduction of immune
checkpoint inhibitors, have led to a fundamental change in advanced cancer treatments …
checkpoint inhibitors, have led to a fundamental change in advanced cancer treatments …
Dynamic change of albumin-bilirubin score is good predictive parameter for prognosis in chronic hepatitis C-hepatocellular carcinoma patients receiving transarterial …
PT Lin, W Teng, WJ Jeng, WT Chen, YC Hsieh… - Diagnostics, 2022 - mdpi.com
Background and Aims: The Albumin-Bilirubin (ALBI) grade is a good index for liver function
evaluation and is also associated with the outcomes of hepatocellular carcinoma patients …
evaluation and is also associated with the outcomes of hepatocellular carcinoma patients …
Prognostic and predictive factors for locoregional and systemic therapies in hepatocellular carcinoma
S Gray, A Lamarca, MG McNamara… - Liver Cancer …, 2023 - Wiley Online Library
Hepatocellular carcinoma (HCC) is a growing health concern, with an estimated global
incidence of over 1 million by 2025. In its intermediate and advanced stages, HCC remains …
incidence of over 1 million by 2025. In its intermediate and advanced stages, HCC remains …
[HTML][HTML] Propensity score matching analysis of efficacy of drug-eluting beads (DEB)-TACE loaded with different drugs in the treatment of hepatocellular carcinoma
L Yang, H Wang, S Li, G Gan, W Deng… - American Journal of …, 2023 - ncbi.nlm.nih.gov
Objective: To evaluate the efficacy of drug-eluting beads transarterial chemoembolization
(DEB-TACE) in the treatment of hepatocellular carcinoma (HCC) by propensity score …
(DEB-TACE) in the treatment of hepatocellular carcinoma (HCC) by propensity score …